Cargando…

Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis

BACKGROUND: Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers and is the 4th most common cancer among men and the tenth most common in women, in the US. There is a constant need to clarify current TCC incidence and mortality rates among different population groups for bett...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Husseini, Muneer J., Kunbaz, Ahmad, Saad, Anas M., Santos, João Vasco, Salahia, Sami, Iqbal, Marium, Alahdab, Fares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327491/
https://www.ncbi.nlm.nih.gov/pubmed/30630456
http://dx.doi.org/10.1186/s12885-019-5267-3
_version_ 1783386477806223360
author Al-Husseini, Muneer J.
Kunbaz, Ahmad
Saad, Anas M.
Santos, João Vasco
Salahia, Sami
Iqbal, Marium
Alahdab, Fares
author_facet Al-Husseini, Muneer J.
Kunbaz, Ahmad
Saad, Anas M.
Santos, João Vasco
Salahia, Sami
Iqbal, Marium
Alahdab, Fares
author_sort Al-Husseini, Muneer J.
collection PubMed
description BACKGROUND: Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers and is the 4th most common cancer among men and the tenth most common in women, in the US. There is a constant need to clarify current TCC incidence and mortality rates among different population groups for better clinical practice guidelines. We aimed to describe the TCC incidence and incidence-based mortality by demographic and tumor-related characteristics over the last 40 years in the US. METHODS: We obtained data from the SEER 18 registries to study TCC cases that were diagnosed between the years 1973 and 2014. We calculated incidence rates and incidence-based mortality rates in different demographic and tumor-related characteristics and expressed rates by 100,000 person-years. We then calculated the annual changes in incidence and incidence-based mortality rates and displayed them as annual percent changes (APCs). RESULTS: There were 182,114 patients with TCC between 1973 and 2014 in the United States. Overall incidence rates of TCC increased 0.16% (95% CI, 0.02–0.30, p = .02) per year over the study period. However, the incidence declined significantly since 2007; (95%CI,-1.89- -0.77, p < .001), except among the elderly and African Americans, which increased significantly over the study period. Overall TCC mortality rates did not change over the study period. However, since 2000 it started to decrease significantly. CONCLUSION: TCC incidence and incidence-based mortality rates had been showing significant increases over the previous decades. However, significant declines in both incidence and incidence-based mortality rates have been observed over the recent years, except in some patients with certain racial groups. Improved understanding of the etiological and ecological factors of TCC could lead to further declines in incidence and incidence-based mortality rates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5267-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6327491
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63274912019-01-15 Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis Al-Husseini, Muneer J. Kunbaz, Ahmad Saad, Anas M. Santos, João Vasco Salahia, Sami Iqbal, Marium Alahdab, Fares BMC Cancer Research Article BACKGROUND: Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers and is the 4th most common cancer among men and the tenth most common in women, in the US. There is a constant need to clarify current TCC incidence and mortality rates among different population groups for better clinical practice guidelines. We aimed to describe the TCC incidence and incidence-based mortality by demographic and tumor-related characteristics over the last 40 years in the US. METHODS: We obtained data from the SEER 18 registries to study TCC cases that were diagnosed between the years 1973 and 2014. We calculated incidence rates and incidence-based mortality rates in different demographic and tumor-related characteristics and expressed rates by 100,000 person-years. We then calculated the annual changes in incidence and incidence-based mortality rates and displayed them as annual percent changes (APCs). RESULTS: There were 182,114 patients with TCC between 1973 and 2014 in the United States. Overall incidence rates of TCC increased 0.16% (95% CI, 0.02–0.30, p = .02) per year over the study period. However, the incidence declined significantly since 2007; (95%CI,-1.89- -0.77, p < .001), except among the elderly and African Americans, which increased significantly over the study period. Overall TCC mortality rates did not change over the study period. However, since 2000 it started to decrease significantly. CONCLUSION: TCC incidence and incidence-based mortality rates had been showing significant increases over the previous decades. However, significant declines in both incidence and incidence-based mortality rates have been observed over the recent years, except in some patients with certain racial groups. Improved understanding of the etiological and ecological factors of TCC could lead to further declines in incidence and incidence-based mortality rates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5267-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-10 /pmc/articles/PMC6327491/ /pubmed/30630456 http://dx.doi.org/10.1186/s12885-019-5267-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Al-Husseini, Muneer J.
Kunbaz, Ahmad
Saad, Anas M.
Santos, João Vasco
Salahia, Sami
Iqbal, Marium
Alahdab, Fares
Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
title Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
title_full Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
title_fullStr Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
title_full_unstemmed Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
title_short Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis
title_sort trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the usa: a seer-based analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327491/
https://www.ncbi.nlm.nih.gov/pubmed/30630456
http://dx.doi.org/10.1186/s12885-019-5267-3
work_keys_str_mv AT alhusseinimuneerj trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis
AT kunbazahmad trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis
AT saadanasm trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis
AT santosjoaovasco trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis
AT salahiasami trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis
AT iqbalmarium trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis
AT alahdabfares trendsintheincidenceandmortalityoftransitionalcellcarcinomaofthebladderforthelastfourdecadesintheusaaseerbasedanalysis